ST 034307

Pricing Availability Delivery Time Qty
Cat.No. 6271 - ST 034307 | C10H4Cl4O2 | CAS No. 133406-29-8
Description: Adenylyl cyclase 1 (AC1) inhibitor; analgesic and active in vivo
Chemical Name: 6-Chloro-2-(trichloromethyl)-4H-1-benzopyran-4-one
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews
Literature

Biological Activity

Adenylyl cyclase 1 (AC1) inhibitor (IC50 = 2.3 μM). Exhibits some selectivity for AC1 over other AC isoforms, with no significant activity against AC8. Inhibits Ca2+/calmodulin-stimulated cAMP accumulation in hippocampal homogenates. Enhances μ opioid receptor (MOR)-mediated inhibition of AC1 in cellular assays and inhibits development and maintenance of MOR-mediated sensitization of AC1. Active in vivo. Analgesic.

Technical Data

M. Wt 297.95
Formula C10H4Cl4O2
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 133406-29-8
PubChem ID 867466
InChI Key NTDHYMSVCBGQJF-UHFFFAOYSA-N
Smiles ClC1=CC=C2OC(C(Cl)(Cl)Cl)=CC(C2=C1)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 29.8 100
ethanol 5.96 20

Preparing Stock Solutions

The following data is based on the product molecular weight 297.95. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 3.36 mL 16.78 mL 33.56 mL
5 mM 0.67 mL 3.36 mL 6.71 mL
10 mM 0.34 mL 1.68 mL 3.36 mL
50 mM 0.07 mL 0.34 mL 0.67 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets

Safety Datasheet

References

References are publications that support the biological activity of the product.

Brust et al (2017) Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties. Sci.Signal. 10 eaah5381 PMID: 28223412


If you know of a relevant reference for ST 034307, please let us know.

View Related Products by Product Action

View all Adenylyl Cyclase Inhibitors

Keywords: ST 034307, ST 034307 supplier, ST034307, adenylyl, cyclase, inhibitors, inhibits, AC1, active, in, vivo, analgesic, cAMP, Adenylyl, Cyclase, 6271, Tocris Bioscience

Citations for ST 034307

Citations are publications that use Tocris products.

Currently there are no citations for ST 034307. Do you know of a great paper that uses ST 034307 from Tocris? Please let us know.

Reviews for ST 034307

There are currently no reviews for this product. Be the first to review ST 034307 and earn rewards!

Have you used ST 034307?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Schizophrenia

Schizophrenia Poster

Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.